WEDNESDAY, Aug. 8, 2018 — Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.
TUESDAY, Aug. 7, 2018 — Overtreatment of thyroid cancers is common, according to a perspective article published in the July 25 issue of the New England Journal of
The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the
FRIDAY, Aug. 3, 2018 — Don’t kid yourself that using a sunless tanning product will prevent skin cancer. Unless you’re willing to stop sunbathing altogether, you’re still at
A major research project from a collaborative of university researchers finds that individual behavioural treatment and support for parents of preschool children with ADHD is significantly better than
WEDNESDAY, Aug. 1, 2018 — Targeted steps can be taken to minimize future risks of lawsuits, according to an article published in Physicians Practice. In order to reduce
South San Francisco, CA — July 25, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive, top line results from
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok